Search
Coming soon.
Amy Hont, M.D., is an attending physician in the Department of Hematology/Oncology and physician-scientist in the Center for Cancer and Immunology Research. Her research interest focuses on the use of targeted therapies, including immunotherapy, for patients with high-risk malignancies.
Michael Hsieh, MD, PhD, is the Director of Transitional Urology. Dr. Hsieh has experience in laparoscopic and robotic surgery for urologic conditions, and specializes in bladder diseases affecting children and young adults.
Yanfen Hu, PhD, studies the role of BRCA1 phosphorylation in DNA DSB repair and genome stability maintenance, as well as drug resistance in BRCA1-associated cancer. Dr.
Dr. Jiyoung Lee is an Assistant Professor in the Department of Biochemistry & Molecular Medicine in the School of Medicine and Health Sciences at the George Washington University. After her Bachelor’s and Master’s degree from Korea University, Dr. Lee obtained her Ph.D.
The Lee Laboratory has over 15 years of experience in the application of molecular, genomics, and computational approaches for elucidating genetic networks and pathways underlying disease processes, such as cancer progression (i.e., metastatic potential, epithelial-mesenchymal transition) and…
Dr. Rong Li has been working in gene regulation and breast cancer biology for more than two decades. He received his Ph.D. degree from the University of California at Berkeley in molecular biology of DNA replication and transcriptional regulation.
Wei Li, PhD, is an Assistant Professor in the Center for Genetic Medicine Research, and a member of the Center for Cancer and Immunology Research at Children’s National Medical Center.
Paul Lin, MD, FACS is currently the Vice Chairman of the Department of Surgery at George Washington University Medical Faculty Associates. He is an Associate Professor of Surgery and the Chief of General Surgery and the Program Director for the General Surgery Residency. Dr.
My research interests are focused on clinical and translational investigations of transfusion safety and include studies of infectious and non-infectious complications of transfusion including RBC and HLA alloimmunization, graft versus host disease and evidence based transfusion practices.